EOM 1352: Fri 7 June 2024, 11:36
Media Pack
News

Current Edition

Volume 17 Issue 4
Discovery Park: Wed 13 November 2024, 10:35
ramusmedical
Europe

Compugen Advancing Cancer Immunotherapies to Clinical Trials

Compugen today said clinical trials will be launched for a pair of its cancer immunotherapy candidates targeting advanced solid tumors—its lead immuno-oncology progra...
4 July 2018 Europe advancing | cancer
Continue Reading →
Europe

Anavex Life Sciences Receives Approval To Initiate Phase 2b/3 Clinical Trial of ANAVEX®2-73 for the Treatment of Early Alzheimer’s Disease

ANAVEX®2-73 Being Studied as Potential First Precision Medicine Biomarker-guided, Targeted Therapeutic in Alzheimer’s Disease Primary and Secondary Endpoints mea...
4 July 2018 Europe | North America anavex | approval
Continue Reading →
Australasia

First Volunteers Dosed in Phase I Clinical Trial of PBT434, Prana’s Lead Therapy for Parkinsonian Diseases

Prana enrols and doses its first cohort of healthy volunteers in its Phase I clinical trial Evidence supports activity of PBT434 to prevent α-synuclein accumulat...
4 July 2018 Australasia | Europe | North America clinical | dosed
Continue Reading →
Europe

NIH Opening First Mesothelioma Clinical Trial for Lynparza

The National Institutes of Health (NIH) in Bethesda, Maryland, is opening the first mesothelioma clinical trial involving the immunotherapy drug Lynparza (olaparib), ...
27 June 2018 Europe clinical | first
Continue Reading →
Europe

Medicare should ‘pay it forward’ on clinical trials

“Innovation,” particularly in health, is a policy buzzword these days. Former House Speaker, Newt Gingrich, penned an opinion piece over the weekend that called on Re...
27 June 2018 Europe | North America | Uncategorized clinical | forward
Continue Reading →
Europe

Summit Therapeutics says PhaseOut DMD clinical trial did not meet primary endpoint

The AIM-listed pharmaceuticals group said that because of the outcome, it is discontinuing its development of ezutromid and as a result, will be implementing cost red...
27 June 2018 Europe clinical | DMD
Continue Reading →
North America

7th International Conference on Clinical Trials

7th International Conference on Clinical Trials is scheduled to be held during September 24-26, 2018 at Chicago, USA. This Clinical Trials Conference includes a wide...
20 June 2018 North America 7th | clinical
Continue Reading →
Europe

Prothena Announces Phase 1b Clinical Trial Results of PRX002/RG7935 for Parkinson’s Disease Published in JAMA Neurology

Prothena Corporation plc (NASDAQ:PRTA), a clinical-stage biotechnology company focused on the discovery and development of novel therapies in the neuroscience categor...
20 June 2018 Europe announces | clinical
Continue Reading →
Europe

Clinical trial targets metastatic colorectal cancer with new combination therapy

Rutgers Cancer Institute of New Jersey is offering a clinical trial targeting an advanced form of colorectal cancer with a combination vaccine/immunotherapy drug trea...
20 June 2018 Europe cancer | clinical
Continue Reading →
Europe

Aminex Therapeutics Initiates First Clinical Trial of Novel Immunotherapy AMXT 1501 + DFMO in Cancer Patients

Polyamine depletion therapy represents a unique cancer immunotherapy approach Aminex Therapeutics, Inc., a clinical-stage drug development company focused on advanc...
20 June 2018 Europe Aminex | clinical
Continue Reading →
Catalyst: 12th January 2026
Quotient

jcs-white.png

Journal for Clinical Studies

Journal For Clinical Studies has a distinguished editorial advisory board providing the best guidelines for global clinical trials. Your resource for Multisite Studies and emerging markets.

Facebook Linkedin
Journal For Clinical Studies © 2026, All Rights Reserved – Powered by Teksyte